Work

Relationship Between Severity of Adverse Events of Afatinib and Its Pharmacokinetics and Pharmacogenomics for EGFR Mutation-Positive Non-Small Cell Lung Cancer

Year: 2019

Type: conference-abstract

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3936

Authors: T. Gomyo, H. Iihara, H. Hayashi, J. Endo, F. Ito, K. Yansase, D. Kaito, Y. Sasaki, C. Sakai, Y. Fukuda, C. Hirose, T. Sugiyama, A. Suzuki, Y. Ohno

Institutions: Gifu University, Gifu University Hospital, Gifu Pharmaceutical University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2970090984

Cites:

Cited by:

Related to: 10